Lv1
30 积分 2025-05-01 加入
Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transporter protein-2
21小时前
已完结
Astragaloside IV attenuates high glucose‐induced NF‐κB‐mediated inflammation through activation of PI3K/AKT‐ERK‐dependent Nrf2/ARE signaling pathway in glomerular mesangial cells
2天前
已完结
Astragaloside IV, as a potential anticancer agent
1个月前
已完结
Astragaloside IV, as a potential anticancer agent
1个月前
已完结
The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review
1个月前
已完结
Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
1个月前
已完结
Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease
1个月前
已完结
Tangshenning Formula Alleviates Tubular Injury in Diabetic Kidney Disease via the Sestrin2/AMPK/PGC-1α Axis: Restoration of Mitochondrial Function and Inhibition of Ferroptosis
1个月前
已完结
Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation
1个月前
已完结
Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy
1个月前
已完结
皖公网安备34019202002308
